CAMBRIDGE, Mass., Oct. 31 /PRNewswire/ -- Xanthus Life Sciences, Inc., a
privately-held oncology drug development company, today announced that it will
be presenting at the following upcoming investment conferences in November:
* Richard T. Dean, Ph.D., Chief Executive Officer, will present at the
Mass Opportunities Investment Conference on November 3, 2005 at 3:40pm
at the Hilton Logan Airport, Boston
* John A. McCarthy, Jr., Senior Vice President & Chief Financial Officer,
will present at the Rodman & Renshaw Techvest 7th Annual Healthcare
Conference on November 9, 2005 at 3:10pm at the Palace Hotel in New
York
* Richard T. Dean, Ph.D., Chief Executive Officer, will present at the
CIBC World Markets Healthcare Conference on November 9, 2005 at 4:00pm
at the Waldorf-Astoria in New York
A live audio webcast of Dr. Dean's presentation at the CIBC World Markets
Healthcare Conference will be available on the Company's website located at
http://www.xanthus.com. A replay of the presentation will be posted on the
Xanthus website approximately thirty minutes after the event.
About Xanthus
Xanthus is developing a portfolio of novel, clinical-stage, small-molecule
oncology candidates. Xanthus' management team has an accomplished track
record in all aspects of drug development, from discovery and development
through regulatory approval and commercialization. The Company is applying
its expertise both to advance its product portfolio and to expand it into
indications of unmet medical need beyond oncology. More information about
Xanthus is available on the Net: http://www.xanthus.com
SOURCE Xanthus Life Sciences, Inc.
 back to top
Related links:
http://www.xanthus.com
CONTACT:
Kari Watson of MacDougall Biomedical
Communications, Inc., +1- 508-647-0209, kwatson@macbiocom.com; or
John A. McCarthy, Jr., SVP & CFO of Xanthus Life Sciences, Inc.,
+1-617-225-0522, ext. 125, john.mccarthy@xanthus.com
|
